Cystic fibrosis-related diabetes testing in Parma
Find health labs to test for Cystic fibrosis-related diabetes in Parma and compare all offers by prices and services.
Diabetes Test by Gemini Srl - Poliambulatorio a Parma
Piazza Sisto Rosa Badalocchio, 3, 43126 Parma PR, Italia
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Hemoglobin Test by Farmacia Beata Vergine della Salute
Corso Canalchiaro, 127, 41121 Modena MO, Italia
31.2 km
Hemoglobin Test by Lab - Analisi Cliniche
Via Paolo Borsellino, 1, 26865 San Rocco al Porto LO, Italia
36.4 km
Hemoglobin Test by Farmacia Pian di Macina
Via Ottavio Garganelli, 13, 40065 Pianoro BO, Italia
57.6 km
Hemoglobin Test by Farmacia Manganelli
Via degli Alpini, 2, 24064 Grumello del Monte BG, Italia
61.7 km
Diabetes Test by Synlab
Via Sorte, 48, 37047 San Bonifacio VR, Italia
61.6 km
Hemoglobin Test by Bianalisi - Punto prelievo Rapallo
Via Pellerano Murtula, 1, 16035 Rapallo GE, Italia
62.3 km
Diabetes Test by Casa della Salute
Largo Milite Ignoto, 1, 16012 Busalla GE, Italia
69.8 km
Diabetes Test by Laboratorio Analisi Cliniche Valle Scrivia SRL - Busalla
Via Luigi Nino Malerba, 28, 16012 Busalla GE, Italia
69.8 km
Hemoglobin Test by Farmacia Picconi
Via Provinciale Montalbano, 371, 51034 Serravalle Pistoiese PT, Italia
66.7 km
Hemoglobin Test by Laboratorio Analisi Cliniche Valle Scrivia SRL - Genova
Via Giuseppe Sapeto, 5A, 16132 Genova GE, Italia
73.7 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
